Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
暂无分享,去创建一个
M. König | J. Harbott | O. Haas | M. Schrappe | A. Attarbaschi | R. Panzer‐Grümayer | A. Möricke | H. Gadner | G. Mann | S. Röttgers | M. Dworzak | M. Seidel | M. Steiner | D. Janousek | E. Csinady | C. Reichelt | R. Panzer-Grümayer